AAK1 activation-mediated iron trafficking drives ferroptotic cell death
Li-Chao Li, Zhi-Peng Ye, Ying Xiao, Xian-Ying Zhu, Qia-Qia Li, Yi-Qing Guo, Huai-Liang Wu, Zhi-Ling Li, Lin-Yu Wu, Yu-Hong Chen, Gong-Kan Feng, Dong Yang, Shan Liu, Bing-Xin Hu, Jia-Hong Tang, Yu-Feng Zhou, Jing Li, Rong Deng, Hai-Liang Zhang, Xiao-Feng Zhu

TL;DR
This study reveals how cells increase iron uptake during ferroptosis through a pathway involving PKCβII, AAK1, and TFR1, which could lead to new cancer therapies.
Contribution
The paper identifies a novel PKCβII-AAK1-AP2M1 pathway that regulates iron uptake during ferroptosis and links it to breast cancer prognosis.
Findings
PKCβII activates AAK1, which phosphorylates AP2M1 to promote TFR1 endocytosis and increase cellular iron levels.
AAK1 non-phosphorylatable mutation inhibits ferroptosis and promotes breast tumor growth in vivo.
The PKCβII-AAK1-AP2M1 pathway is correlated with the prognosis of breast cancer patients.
Abstract
Ferrous iron is necessary for the occurrence of ferroptosis. The molecular mechanisms that maintain iron homeostasis within cells play a crucial role in the regulation of ferroptosis. However, how cells regulate iron uptake during ferroptosis remains unclear. Here, PKCβII is identified as a key kinase mediating transferrin receptor 1 (TFR1) endocytosis through phosphorylation and activation of AP2-associated protein kinase 1 (AAK1) during the ferroptotic process. Mechanistically, activated AAK1 phosphorylates AP2M1, which facilitates the recruitment of clathrin to mediate the endocytosis of TFR1, increasing the levels of both cellular total iron and ferrous iron and thereby promoting ferroptosis. The non-phosphorylatable mutation of AAK1 inhibits ferroptosis and consequently promotes breast tumor growth in vivo. In conclusion, we identify that the PKCβII-AAK1-AP2M1 pathway is a crucial…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFerroptosis and cancer prognosis · Iron Metabolism and Disorders · Clusterin in disease pathology
